Amplify Seymour Cannabis ETF

Frequently Asked Questions About CNBS

What does CNBS invest in?

CNBS is an actively managed exchange-traded fund designed to offer broad U.S. market access to the cannabis sector. It invests across the diverse landscape of this industry, encompassing companies involved in cannabis cultivation (plants), essential operational support, and various ancillary businesses. The primary aim of CNBS is to generate capital appreciation for its investors.

What is the expense ratio of CNBS?

Amplify Seymour Cannabis ETF (CNBS) charges an expense ratio of 1.09%. This is the annual fee deducted from fund assets to cover management and operations.

How big is CNBS?

Amplify Seymour Cannabis ETF (CNBS) manages $73.3M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is CNBS actively managed or an index fund?

CNBS is actively managed — the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (CNBS's is 1.09%) in exchange for the discretion to over- or under-weight positions.

When was CNBS launched?

Amplify Seymour Cannabis ETF (CNBS) launched in July 2019 and is managed by Amplify.

How has CNBS performed?

CNBS's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.